Fernández-Castañer M - Search Results

1

The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels.

Fernández-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernández-Castañer M, Vendrell J, Richart C, Soler J. Fernández-Real JM, et al. Diabetes. 1997 Sep;46(9):1468-72. doi: 10.2337/diab.46.9.1468. Diabetes. 1997. PMID: 9287048

2

Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin.

Biarnés J, Fernández-Real JM, Fernández-Castañer M, del Mar García M, Soler J, Ricart W. Biarnés J, et al. Among authors: fernandez castaner m. Metabolism. 2005 Feb;54(2):235-9. doi: 10.1016/j.metabol.2004.08.018. Metabolism. 2005. PMID: 15690319 Clinical Trial.

3

Serum ferritin as a component of the insulin resistance syndrome.

Fernández-Real JM, Ricart-Engel W, Arroyo E, Balançá R, Casamitjana-Abella R, Cabrero D, Fernández-Castañer M, Soler J. Fernández-Real JM, et al. Diabetes Care. 1998 Jan;21(1):62-8. doi: 10.2337/diacare.21.1.62. Diabetes Care. 1998. PMID: 9580307

4

Improved metabolic control preserved beta-cell function two years after diagnosis of insulin-dependent diabetes mellitus.

Montanya E, Fernandez-Castañer M, Soler J. Montanya E, et al. Diabetes Metab. 1997 Sep;23(4):314-9. Diabetes Metab. 1997. PMID: 9342545 Clinical Trial.

5

Insulin regulation of leptin synthesis and secretion in humans: the model of myotonic dystrophy.

Gómez JM, Molina A, Fernández-Castañer M, Casamitjana R, Martínez-Matos JA, Soler J. Gómez JM, et al. Among authors: fernandez castaner m. Clin Endocrinol (Oxf). 1999 May;50(5):569-75. doi: 10.1046/j.1365-2265.1999.00675.x. Clin Endocrinol (Oxf). 1999. PMID: 10468921

6

Leptin in type 2 diabetic or myotonic dystrophic women.

Gómez JM, Molina A, Fernández-Castañer M, Soler J. Gómez JM, et al. Among authors: fernandez castaner m. Horm Metab Res. 2001 Apr;33(4):246-9. doi: 10.1055/s-2001-14944. Horm Metab Res. 2001. PMID: 11383930

7

Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity.

Fernández-Castañer M, Molina A, López-Jiménez L, Gómez JM, Soler J. Fernández-Castañer M, et al. Diabetes Care. 1999 Mar;22(3):377-81. doi: 10.2337/diacare.22.3.377. Diabetes Care. 1999. PMID: 10097913

8

[Insulin resistance and metabolic syndrome in first-degree relatives of patients with NIDDM].

Camps I, Biarnés J, Fernández-Real JM, Insa R, Soler J, Fernández Castañer M. Camps I, et al. Med Clin (Barc). 1999 Mar 6;112(8):281-4. Med Clin (Barc). 1999. PMID: 10207842 Spanish.

9

Body composition assessment in type 1 diabetes mellitus patients over 15 years old.

Gómez JM, Maravall FJ, Soler J, Fernández-Castañer M. Gómez JM, et al. Among authors: fernandez castaner m. Horm Metab Res. 2001 Nov;33(11):670-3. doi: 10.1055/s-2001-18688. Horm Metab Res. 2001. PMID: 11733870

10

Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.

Fernandez Castañer M, Montaña E, Camps I, Biarnes J, Merino JF, Escriba JM, Nacher V, Rosel P, Soler J. Fernandez Castañer M, et al. Diabetes Metab. 1996 Oct;22(5):349-55. Diabetes Metab. 1996. PMID: 8896997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters